首页|肝硬化门静脉高压相关血清学指标研究进展

肝硬化门静脉高压相关血清学指标研究进展

扫码查看
门静脉高压(PH)是最常见的由肝硬化引起的一组临床综合征,其发生与肝纤维化、肝内血流阻力及血管生成等密切相关。肝硬化PH时,一些炎症介质、血管活性物质等血清学指标发生变化。近年来,这些指标逐渐被作为PH无创诊断的血清学标志物,可预测PH及肝硬化并发症的发生、发展。因此,本文就肝硬化PH相关血清学指标研究进展进行综述。
Research progress of serological indicators related to portal hypertension in cirrhosis
Portal hypertension(PH)is a group of clinical syndromes,the most common cause of which is cir-rhosis.Its occurrence is closely related to liver fibrosis,intrahepatic blood flow resistance and angiogenesis.When liver cirrhosis portal hypertension occurs,some inflammatory mediators,vasoactive substances and oth-er serological indicators change during PH in cirrhosis.In recent years,these indicators have gradually been used as serological markers for non-invasive diagnosis of PH,which can predict the occurrence and develop-ment of portal hypertension and liver cirrhosis complications.Therefore,this article reviews the research prog-ress on serological indicators of portal hypertension in liver cirrhosis.

liver cirrhosisportal hypertensionserologynon-invasive diagnosis

蒋彤、邓悦、陈灵、文皓、石国庆

展开 >

遵义医科大学附属医院 消化内科,贵州 遵义 563000

遵义医科大学第五附属(珠海)医院消化内科,广东 珠海 519100

肝硬化 门静脉高压 血清学 无创诊断

贵州省科技计划省部共建协同创新中心项目

黔科合成果20204Y004教科技厅函202039号

2024

兰州大学学报(医学版)
兰州大学

兰州大学学报(医学版)

CSTPCD
影响因子:0.641
ISSN:1000-2812
年,卷(期):2024.50(5)
  • 5